Nurami’s preliminary product is ArtiFascia®, a highly effective surgical patch with an integrated, temperature sensitive, non-porous barrier film . ArtiFascia® has successfully completed pivotal clinical trials in 85 participants, including a 6-month follow-up, and will be market ready in 2023. Our pipeline incudes ArtiFix®, a soft tissue sealant patch, which is designed to not require suturing and NovaFibreX^TM, a ground-breaking surgical adhesive for general surgery, which will be designed to withstand premature degradation while adhering effectively to the wet environment of internal organs.

*ArtiFascia, ArtiFix and NovaFibreX are for investigational use only